Feasibility of Carbidopa Premedication in Pediatric Patients: A Pilot Study

18F-DOPA PET/CT in Neuroblastoma

(2012) Egesta Lopci et al.   CLINICAL NUCLEAR MEDICINE

Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study

(2011) Arnoldo Piccardo et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Neuroblastoma Imaging

(2010) S. Ley et al.   ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN

6-[F-18]Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess

(2009) Helle-Brit Fiebrich et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

18F-FDOPA: A Multiple-Target Molecule

(2009) H. Minn et al.   JOURNAL OF NUCLEAR MEDICINE

Manipulation of [11C]-5-Hydroxytryptophan and 6-[18F]Fluoro-3,4-Dihydroxy-L-Phenylalanine Accumulation in Neuroendocrine Tumor Cells

(2008) O. C. Neels et al.   CANCER RESEARCH

Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the diagnosis and localization of non-metastatic and metastatic phaeochromocytoma (PHEO)

(2008) Henri J. L. M. Timmers et al.   CLINICAL ENDOCRINOLOGY

Premedication With Carbidopa Masks Positive Finding of Insulinoma and β-Cell Hyperplasia in [18F]-Dihydroxy-Phenyl-Alanine Positron Emission Tomography

(2008) Saila Kauhanen et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved Staging of Patients With Carcinoid and Islet Cell Tumors With 18F-Dihydroxy-Phenyl-Alanine and 11C-5-Hydroxy-Tryptophan Positron Emission Tomography

(2008) Klaas P. Koopmans et al.   JOURNAL OF CLINICAL ONCOLOGY

6-L-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications

(2008) P. L. Jager et al.   JOURNAL OF NUCLEAR MEDICINE